PHIO today
$0.85+$0.03 (+4.03%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourLeaning Bullish
1 hourDescending Triangle
15 minStrong Bullish
5 minConsolidating
Daily trend turns up above $0.92
Key levels
Resistance$0.92
Resistance$0.85
Support$0.75
Latest news & SEC filings
SEC FilingPhio Pharmaceuticals Corp. filed an insider trading report (Form 4)
ProductPhio Pharmaceuticals to share Phase 1b data at 41st SITC meeting
EarningsPhio Pharmaceuticals posts Q3 2026 results, business update
All PHIO news →About Phio Pharmaceuticals
Phio Pharmaceuticals develops cancer immunotherapies using its INTASYL gene-silencing RNA platform, which aims to help immune cells destroy tumor cells. Its main candidate, PH-762, targets the PD-1 protein and is being tested in patients with several types of skin cancer. The company is based in the United States and contracts with outside manufacturers to produce its drug candidates.
Based on the company's 10-K filed Mar 5, 2026.
Nasdaq · Healthcare
Phio Pharmaceuticals Corp. (PHIO)
What Is the Price Target for PHIO?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is PHIO a Buy or Sell Right Now?
Thesis
- •Smart money flows are positive — institutional and insider activity shows net buying.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for PHIO.
Start Free Trial →Is PHIO Overvalued or Undervalued?
Valuation Verdict
N/A
Methods Used
N/A
Fair Value
$N/A
12
Moat Score
NONE
3/9
Piotroski Score
-9.2
Altman Z-Score
What Is Smart Money Doing with PHIO?
Insider Signal
BUYING
5 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Bitterman Robert J | director officer | Buy | 25,000 | $21K | Nov 9, 2026 |
| Plott Ronald Todd | director | Buy | 18,300 | $15K | Nov 9, 2026 |
| Plott Ronald Todd | director | Buy | 5,000 | $5K | Sep 29, 2026 |
| Bitterman Robert J | director officer | Buy | 400,000 | - | Sep 28, 2026 |
| Plott Ronald Todd | director | Buy | 17,000 | - | Sep 28, 2026 |
| Carson Lisa Cabott | officer | Buy | 108,000 | - | Sep 28, 2026 |
| Plott Ronald Todd | director | Buy | 5,000 | $5K | Sep 28, 2026 |
| BRADFORD PATRICIA A | director | Buy | 6,500 | $7K | Sep 24, 2026 |
| Bitterman Robert J | director officer | Buy | 2,000 | $2K | Sep 22, 2026 |
| BRADFORD PATRICIA A | director | Buy | 12,000 | $12K | Sep 15, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →PHIO Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
N/A
FCF Growth YoY
-12.3%
Revenue Trend
UNKNOWN
Dark Pool Trades for PHIO
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for PHIO, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 18:55:18 | $0.81 | 1,200 | $$968 | SELL |
| 18:51:17 | $0.82 | 1,043 | $$859 | SELL |
| 18:51:17 | $0.82 | 1,005 | $$827 | SELL |
| 18:51:17 | $0.82 | 1,043 | $$859 | SELL |
| 18:51:17 | $0.82 | 1,005 | $$827 | SELL |
5 dark pool trades shown · $$4K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Phio Pharmaceuticals Corp. (PHIO) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →PHIO — frequently asked questions
What is PHIO stock price today?
Phio Pharmaceuticals Corp. (PHIO) is at $0.85, up 4.03% (+$0.03) at the Nov 12, 2026 close.
Why is PHIO stock moving today?
Latest PHIO news — Nov 10, 2026: Phio Pharmaceuticals Corp. filed an insider trading report (Form 4) · Nov 7, 2026: Phio Pharmaceuticals to share Phase 1b data at 41st SITC meeting
What do analysts rate PHIO?
Analyst ratings for PHIO: 0 Buy, 1 Hold, 0 Sell — consensus Hold.
Did PHIO beat earnings?
PHIO last reported on Aug 6, 2026: EPS -$0.36 vs -$0.36 expected — in line.
Does PHIO pay a dividend?
PHIO does not currently pay a dividend.
What are PHIO support and resistance levels?
Support: $0.75. Resistance: $0.85, $0.92, $0.99.
What are insiders doing with PHIO?
Insider activity: BUYING, 5 buys and 0 sells in the last 90 days.
What is the latest news on PHIO?
Nov 10, 2026: Phio Pharmaceuticals Corp. filed an insider trading report (Form 4) · Nov 7, 2026: Phio Pharmaceuticals to share Phase 1b data at 41st SITC meeting · Nov 7, 2026: Phio Pharmaceuticals posts Q3 2026 results, business update